New line of therapy for acute myeloid leukaemia

Novel agent CC-292 for CLL using the B-cell receptor pathway

Encouraging early results with GS-9973 for CLL and NHL

PI3K-delta inhibitor idelalisib success in CLL

T cell immunotherapy for leukaemia in preclinical setting

New agents in CLL

Chronic lymphocytic leukaemia: A new treatment era is born

Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab

Immune reconstitution and preliminary safety analysis of somatic gene therapy

Immunotherapy in metastatic kidney cancer

Cancer cells and the immune system: a natural story?

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction